| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JTOS.2015.07.003 |
| P8608 | Fatcat ID | release_ngjkustmlrexlanehflfc4o3ju |
| P932 | PMC publication ID | 4706470 |
| P698 | PubMed publication ID | 26387870 |
| P5875 | ResearchGate publication ID | 282048388 |
| P2093 | author name string | Scheffer C G Tseng | |
| Dandan Zhao | |||
| Anny M S Cheng | |||
| Victoria Casas | |||
| Hosam Sheha | |||
| Sean Tighe | |||
| Han Y Yin | |||
| Rendian Chen | |||
| P2860 | cites work | Critical appraisal of ex vivo expansion of human limbal epithelial stem cells. | Q27690874 |
| Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation | Q74299362 | ||
| Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix | Q77402145 | ||
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347909 | ||
| Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome | Q81151525 | ||
| Repair of necrotizing scleritis in ulcerative colitis with processed pericardium and a Prokera amniotic membrane graft | Q84887923 | ||
| Corneal nerve structure and function in patients with non-sjogren dry eye: clinical correlations | Q87056282 | ||
| Virologic and immunologic events in hilar lymph nodes during simian immunodeficiency virus infection: development of polarized inflammation | Q95781414 | ||
| Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix | Q28361114 | ||
| Reduction in corneal haze and apoptosis by amniotic membrane matrix in excimer laser photoablation in rabbits | Q30982392 | ||
| Amniotic membrane induces apoptosis of interferon-gamma activated macrophages in vitro | Q33221949 | ||
| Changes in corneal epithelial layer inflammatory cells in aqueous tear-deficient dry eye. | Q33486416 | ||
| Constitutive expression of pentraxin 3 (PTX3) protein by human amniotic membrane cells leads to formation of the heavy chain (HC)-hyaluronan (HA)-PTX3 complex. | Q33676745 | ||
| Sutureless amniotic membrane transplantation for partial limbal stem cell deficiency | Q33735379 | ||
| Sutureless amniotic membrane transplantation for severe bacterial keratitis | Q33755631 | ||
| Temporary sutureless amniotic membrane patch for acute alkaline burns | Q33767913 | ||
| Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis | Q33786399 | ||
| The diagnosis and management of dry eye: a twenty-five-year review | Q34048201 | ||
| In toto differentiation of human amniotic membrane towards the Schwann cell lineage. | Q34380694 | ||
| Dry eye medication use and expenditures: data from the medical expenditure panel survey 2001 to 2006. | Q34380941 | ||
| Dry eye disease: the scale of the problem | Q34391914 | ||
| Amniotic membrane transplantation for ocular surface reconstruction | Q34568250 | ||
| On the influence of neutrophils in corneas with necrotizing HSV-1 keratitis following amniotic membrane transplantation | Q35532425 | ||
| Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation | Q35895208 | ||
| In vivo downregulation of innate and adaptive immune responses in corneal allograft rejection by HC-HA/PTX3 complex purified from amniotic membrane | Q36103380 | ||
| Suppression of activation and induction of apoptosis in RAW264.7 cells by amniotic membrane extract. | Q36946729 | ||
| Immobilized heavy chain-hyaluronic acid polarizes lipopolysaccharide-activated macrophages toward M2 phenotype | Q37150998 | ||
| Prevalence, burden, and pharmacoeconomics of dry eye disease. | Q37152821 | ||
| The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca. | Q37257746 | ||
| Limbal stem cell transplantation: new progresses and challenges | Q37355697 | ||
| Sutureless amniotic membrane ProKera for ocular surface disorders: short-term results | Q38128988 | ||
| Scleral lens use in dry eye syndrome | Q38443593 | ||
| Minimal conjunctival limbal autograft for total limbal stem cell deficiency | Q39513656 | ||
| The role of NGF signaling in human limbal epithelium expanded by amniotic membrane culture. | Q40649834 | ||
| Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK. | Q40750355 | ||
| Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders | Q40808690 | ||
| Ocular surface rehabilitation: Application of human amniotic membrane in high-risk penetrating keratoplasties | Q41902660 | ||
| Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis | Q46102967 | ||
| Suppression of inflammatory and fibrotic responses in allergic inflammation by the amniotic membrane stromal matrix. | Q46594179 | ||
| Efficacy and limitation of sutureless amniotic membrane transplantation for acute toxic epidermal necrolysis | Q46813076 | ||
| Evaluation of visual acuity and color vision in normal human eyes with a sutureless temporary amniotic membrane patch. | Q50888711 | ||
| A practical treatment algorithm for managing ocular surface and tear disorders. | Q51530225 | ||
| Evaluation of the role of ProKera in the management of ocular surface and orbital disorders. | Q51828367 | ||
| An NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eye. | Q54576777 | ||
| Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas | Q73640360 | ||
| Suppression of TGF-beta signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane | Q73778859 | ||
| Reliability and validity of the Ocular Surface Disease Index | Q73801624 | ||
| P433 | issue | 1 | |
| P921 | main subject | cryopreservation | Q1144664 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 56-63 | |
| P577 | publication date | 2015-09-17 | |
| P1433 | published in | The Ocular Surface | Q15764153 |
| P1476 | title | Accelerated Restoration of Ocular Surface Health in Dry Eye Disease by Self-Retained Cryopreserved Amniotic Membrane | |
| P478 | volume | 14 |
| Q91827415 | AS-OCT Guided Treatment Of Diffuse Conjunctival Squamous Cell Carcinoma With Resection, Amniotic Membrane Graft And Topical Mitomycin C |
| Q47590418 | Adjunctive role of self-retained cryopreserved amniotic membrane in treating immune-related dry eye disease |
| Q92442286 | Advances in dry eye disease treatment |
| Q92066345 | Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis |
| Q46718255 | Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease |
| Q47444216 | Efficacy of self-retained cryopreserved amniotic membrane for treatment of neuropathic corneal pain |
| Q43075719 | Neuropathic Corneal Pain: Approaches for Management |
| Q64929763 | Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease. |
| Q96305325 | Self-retained cryopreserved amniotic membrane in treating acute ocular graft-versus-host-disease (oGVHD) |
| Q92058527 | The use of self-retained, cryopreserved amniotic membrane for the treatment of Sjögren syndrome: a case series |
| Q55009490 | Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study. |
| Q47424328 | Update in Current Diagnostics and Therapeutics of Dry Eye Disease. |
| Q93162303 | Validation and assessment of an antibiotic-based, aseptic decontamination manufacturing protocol for therapeutic, vacuum-dried human amniotic membrane |
Search more.